21 hours ago • geneonline.com
FDA Advisory Panel Rejects Expanded Use of Pfizer’s Talzenna for Prostate Cancer as AI Gains Traction in Improving Clinical Trial Diversity
21 hours ago • geneonline.com
FDA Advisory Panel Rejects Expanded Use of Pfizer’s Talzenna for Prostate Cancer as AI Gains Traction in Improving Clinical Trial Diversity2025-06-13 • urotoday.com
Subgroup Analysis Confirms Darolutamide Efficacy in Black Prostate Cancer Patients - Quoc-Dien Trinh2025-06-13 • PR Newswire
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging2025-06-13 • prnewswire.co.uk
Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Greece2025-06-11 • urologytimes.com
Phase 1 study launches of novel CYP11A1 inhibitor for mCRPC2025-06-06 • businesswire.com
Acerand Therapeutics Initiates First In Human Phase I Clinical Trial Of Ace 232 A Novel Cyp11a1 Inhibitor For Advanced Prostate Cancer2025-06-05 • geneonline.com
FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer Following ARANOTE Trial Results2025-06-04 • ascopost.com
Niraparib Plus Abiraterone in HRR-Mutant Metastatic Castration-Sensitive Prostate Cancer2025-06-04 • clinicaltrialsarena.com
Novartis reports topline outcomes from trial of Pluvicto for prostate cancer2025-06-04 • webwire.com
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer2025-06-03 • PR Newswire
ZERO Prostate Cancer Urges Congress to Protect Lifesaving Cancer Research and Prevention Funding2025-06-03 • EIN Presswire
Scientists develop AI method to predict overall survival rate of prostate cancer patients2025-06-02 • businesswireindia.com
Sarvodaya Hospital, Faridabad Becomes India’s First Theranostics Center to Offer Terbium-161 PSMA Therapy for Advanced Prostate Cancer Patients2025-06-01 • PR Newswire
Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer2025-05-31 • biospace.com
New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology2025-05-31 • businesswire.com
CORRECTING and REPLACING New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology2025-05-31 • newswise.com
UC Davis Clinical Trial Shows Biomarkers May Hold Clue in Treating Aggressive Prostate Cancer2025-05-30 • prnewswire.co.uk
Isotopia and Cardirad Announce Launch of Isoprotrace® in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging2025-05-29 • businesswire.com
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases2025-05-29 • in.investing.com
Candel Therapeutics gains FDA RMAT status for prostate cancer therapy2025-05-29 • stocktitan.net
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer2025-05-28 • stocktitan.net
Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation2025-05-27 • PR Newswire
Bot Image prostate AI leads the battle against prostate cancer: Lessons from a former President diagnosis2025-05-27 • manilatimes.net
Juri Biosciences, a TCG Labs Soleil Portfolio Company, and EpimAb Biotherapeutics Enter into a Worldwide Licensing Agreement for KLK2-Directed T-Cell Engager in Metastatic Prostate Cancer2025-05-26 • sloughobserver.co.uk
New trial at Frimley Health could transform prostate cancer care2025-05-24 • fiercebiotech.com
Candel sheds more light on successful late-stage trial of prostate cancer immunotherapy2025-05-24 • in.investing.com
Candel’s phase 3 trial for prostate cancer therapy shows promise2025-05-24 • clinicaltrialsarena.com
Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial2025-05-24 • stocktitan.net
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 20252025-05-23 • PR Newswire
Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer17 minutes ago • prnewswire.co.uk
Canadian hospital system leverages Sectra's AI service to enhance patient care and workflow efficiency1 hour ago • nagalandtribune.in
Tripura has begun experimental soilless hydroponic farming: Minister1 hour ago • prnewswire.co.uk
Tetragon Financial Group Limited Announces Sale of Minority Equitix Stake to Hunter Point Capital3 hours ago • businesswireindia.com
Mirai School of Technology Is Changing Engineering in India - Here’s How Students Are Learning AI from Day One3 hours ago • prnewswire.co.uk
Education Cannot Wait for the Children of Africa7 hours ago • prnewswire.co.uk
A new lens on regulation: The Modern Regulator launches to track the evolving landscape of regulation across Australia, New Zealand, the UK and beyond16 hours ago • sports.yahoo.com
Toyota unveils hydrogen-powered test car at Le Mans 24 Hours16 hours ago • theglobeandmail.com
Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%16 hours ago • foxbusiness.com
Bethenny Frankel sells her Connecticut mansion for nearly $8M after major renovation16 hours ago • ept.ca
1200V SiC MOSFET delivers top-side cooling, isolated thermal path16 hours ago • organiser.org
Kerala Indian Coast Guard Secures Drifting Cargo Ship Mv Wan Hai 503 Off Kochi16 hours ago • marketbeat.com
Nano Dimension (NASDAQ:NNDM) Issues Quarterly Earnings Results16 minutes ago • EIN Presswire
12-Year-Old SoCal Karate Champion to Represent Team USA at WKC World Championships and World Martial Arts Games17 minutes ago • PR Newswire
IBTA Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - IBTA17 minutes ago • PR Newswire
Performance Brokerage Services Advises on the Sale of Palmdale Kia in California from Top-40 Dealership Group, Nouri/Shaver Automotive Group to Trust Auto Group2025-06-14 • eutoday.net
EU Set to Demand Full Disclosure of Russian Gas Contracts as Part of 2027 Phase-Out Plan21 hours ago • agronews.ua
EU introduces tariffs on all agricultural imports from Russia21 hours ago • nikvesti.com
Chemical plant producing components for explosives attacked in Russia16 hours ago • thestatesman.com
UP constructs 37,403 farm ponds to boost irrigation, launches online application for 2025–261 hour ago • nagalandtribune.in
Tripura has begun experimental soilless hydroponic farming: Minister3 hours ago • businesswireindia.com
Mirai School of Technology Is Changing Engineering in India - Here’s How Students Are Learning AI from Day One1 minute ago • EIN Presswire
Rail Brace Market to Hit USD 95.1 Billion by 2035 Driven by Infrastructure Growth and Rising Safety Standards13 hours ago • EIN Presswire
WebsiteDesigners.London Future-Proofs SEO and Web Design with Built-In AI Visibility Optimisation46 minutes ago • EIN Presswire
Pet Care Market to Reach USD 483.5 Billion by 2035, Driven by Pet Humanization, Premiumization, and Tech AdvancementsStay ahead with real-time headlines from top sources, categorized by sector and country.